Altering the injury microenvironment with a macrophage and Schwann Cell recruiting extracellular matrix-based hydrogel to improve laryngeal nerve injury recovery
Award amount
$274,315Program and phase
SBIR · Phase IAward year
2019Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- RENERVA, INC.
- Proposal award date
- 2019-09-01
- Contract end date
- 2021-02-28
- UEI
- LJ97PLMMTGV1
- Solicitation number
- PA18-574
- Topic code
- NIDCD
Research abstract
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- PNM-CAP: A novel nerve cap to prevent painful neuroma formation in peripheral nerve injuries and amputations
- Restoration of Neuromuscular Function Following Critical Nerve Gap Injuries
- Restoration of Muscular Function Following Direct Muscle Neurotization
- SBIR Phase II:A novel peripheral nerve matrix platform for severe acute peripheral nerve injuries
- SBIR Phase I: Development of a Peripheral Nerve Matrix Conduit to Enable Nerve Regeneration
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- Cell type-specific gene therapy approach for TOMT-linked congenital hearing loss
- Real time speech enhancement/noise reduction for the hearing impaired
- Development of a Navigation-Based Insertion Tool for Trajectory Optimization during Cochlear Implantation
- Phonocath - An endovascular medical device to objectively evaluate Pulsatile Tinnitus
- Smartphone based custom-fit and low-cost hearing aids manufacturing system
Research funding history
6 SBIR/STTR records share this UEI (2019–2025). Reported award amounts total $2,990,439. Reported amounts are not federal obligations.
Phases: Phase I, Phase II
Agencies: Department of Health and Human Services, National Science Foundation